Boston Partners Trims Holdings in Clarivate Plc (NYSE:CLVT)

Boston Partners cut its stake in Clarivate Plc (NYSE:CLVT) by 1.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,367,351 shares of the company’s stock after selling 66,100 shares during the period. Boston Partners owned 0.61% of Clarivate worth $22,197,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in the stock. Thompson Siegel & Walmsley LLC raised its stake in shares of Clarivate by 14.4% in the 4th quarter. Thompson Siegel & Walmsley LLC now owns 10,498,588 shares of the company’s stock valued at $53,333,000 after purchasing an additional 1,323,329 shares in the last quarter. Perpetual Ltd raised its stake in Clarivate by 24.6% during the fourth quarter. Perpetual Ltd now owns 9,192,680 shares of the company’s stock valued at $46,699,000 after buying an additional 1,816,936 shares in the last quarter. Geode Capital Management LLC lifted its holdings in Clarivate by 8.6% during the 3rd quarter. Geode Capital Management LLC now owns 7,243,336 shares of the company’s stock worth $51,443,000 after buying an additional 571,289 shares during the last quarter. FMR LLC increased its holdings in shares of Clarivate by 8.6% in the 3rd quarter. FMR LLC now owns 5,088,942 shares of the company’s stock valued at $36,131,000 after acquiring an additional 401,920 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. raised its position in shares of Clarivate by 0.8% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 4,604,449 shares of the company’s stock valued at $32,692,000 after acquiring an additional 38,355 shares in the last quarter. 85.72% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Separately, Royal Bank of Canada reiterated a “sector perform” rating and set a $6.00 target price on shares of Clarivate in a research note on Thursday, February 20th.

Clarivate Stock Down 2.2 %

Shares of Clarivate stock opened at $4.30 on Friday. Clarivate Plc has a twelve month low of $3.96 and a twelve month high of $7.77. The stock has a market capitalization of $2.96 billion, a price-to-earnings ratio of -4.47 and a beta of 1.28. The company has a current ratio of 0.87, a quick ratio of 0.88 and a debt-to-equity ratio of 0.88. The business’s 50 day simple moving average is $4.81 and its 200-day simple moving average is $5.53.

Clarivate declared that its Board of Directors has initiated a stock repurchase plan on Monday, December 16th that permits the company to buyback $500.00 million in shares. This buyback authorization permits the company to buy up to 12.8% of its shares through open market purchases. Shares buyback plans are usually an indication that the company’s board believes its stock is undervalued.

Clarivate Profile

Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.